Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues

Massimo Franchini; Antonella Tufano; Antonio Coppola

doi:10.1055/s-0041-1733926

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2021; 47(08): 896-898
DOI: 10.1055/s-0041-1733926

Preface

Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues

Massimo Franchini

¹Department of Haematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy

,

Antonella Tufano

²Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy

,

Antonio Coppola

³Department of General and Specialist Medicine, Hub Center for Inherited Bleeding Disorders, University Hospital, Parma, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 Tufano A, Coppola A, Galderisi M. The growing impact of cardiovascular oncology: epidemiology and pathophysiology. Semin Thromb Hemost 2021; 47 (08) 899-906
2 Ortega Pérez R, Sanz AP, Gutiérrez VG, Zamorano Gómez JL. Cardiovascular oncology: the need for a multidisciplinary approach?. Semin Thromb Hemost 2021; 47 (08) 907-913
3 Prandoni P, Campello E. Venous thromboembolism in cancer patients undergoing chemotherapy: risk factors and prevention. Semin Thromb Hemost 2021; 47 (08) 914-919
4 Hansen RS, Nybo M, Hvas A-M. Venous thromboembolism in pediatric cancer patients with central venous catheter—a systematic review and meta-analysis. Semin Thromb Hemost 2021; 47 (08) 920-930
5 Cohen O, Caiano LM, Tufano A, Ageno W. Cancer-associated splanchnic vein thrombosis. Semin Thromb Hemost 2021; 47 (08) 931-941
6 Franchini M, Tufano A, Casoria A, Coppola A. Arterial thrombosis in cancer patients: an update. Semin Thromb Hemost 2021; 47 (08) 942-949
7 Santoro C, Capone V, Canonico ME. et al. Single, dual and triple antithrombotic therapy in cancer patients with coronary artery disease: searching for evidence and personalized approaches. Semin Thromb Hemost 2021; 47 (08) 950-961
8 Falanga A, Marchetti M, Russo L. Hemostatic biomarkers and cancer prognosis: where do we stand?. Semin Thromb Hemost 2021; 47 (08) 962-971
9 Candeloro M, Guman NAM, Kraaijpoel N, Di Nisio M. Risk assessment models for thrombosis and anticoagulant-related bleeding in ambulatory cancer patients. Semin Thomb Hemost 2021; 47 (08) 972-981
10 Rossetti P, Goldoni M, Pengo V. et al. MiRNA 126 as a new predictor biomarker in venous thromboembolism of persistent residual vein obstruction: a pilot study. Semin Thromb Hemost 2021; 47 (08) 982-991
11 Franchini M, Bezzi M, Spreafico F. et al. Acquired factor VII deficiency associated with bronchogenic carcinoma: a case report. Semin Thromb Hemost 2021; 47 (08) 992-994